Size and growth in 33 countries and regions, with clinical trials and research from public sources.
Market size in 2023 · growth a year to 2033
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $17.7 Bn | $31.5 Bn | 5.9% | – | – | Report on Defibrillator in Global |
| North America | $8.9 Bn | $14.3 Bn | 4.9% | 50% | – | Report on Defibrillator in North America |
| APAC | $3.7 Bn | $7.4 Bn | 7.2% | 21% | – | Report on Defibrillator in APAC |
| Europe | $3.4 Bn | $5.3 Bn | 4.6% | 19% | – | Report on Defibrillator in Europe |
| Latin America | $798 Mn | $1.6 Bn | 6.9% | 4.5% | – | Report on Defibrillator in Latin America |
| Middle East | $709 Mn | $1.4 Bn | 6.9% | 4% | – | Report on Defibrillator in Middle East |
| Africa | $266 Mn | $543 Mn | 7.4% | 1.5% | – | Report on Defibrillator in Africa |
| $7.4 Bn | $10.9 Bn | 3.9% | 42% | – | Report on Defibrillator in US | |
| $1.4 Bn | $2.9 Bn | 7.4% | 8% | – | Report on Defibrillator in China | |
| $1.4 Bn | $2.5 Bn | 5.9% | 8% | – | Report on Defibrillator in Canada | |
| $1.1 Bn | $2 Bn | 6.4% | 6.2% | – | Report on Defibrillator in Japan | |
| $649 Mn | $970 Mn | 4.1% | 3.7% | – | Report on Defibrillator in Germany | |
| $488 Mn | $787 Mn | 4.9% | 2.8% | – | Report on Defibrillator in France | |
| $461 Mn | $676 Mn | 3.9% | 2.6% | – | Report on Defibrillator in UK | |
| $443 Mn | $864 Mn | 6.9% | 2.5% | – | Report on Defibrillator in Brazil | |
| $426 Mn | $720 Mn | 5.4% | 2.4% | – | Report on Defibrillator in Italy | |
| $355 Mn | $667 Mn | 6.5% | 2% | – | Report on Defibrillator in Ecuador | |
| $342 Mn | $552 Mn | 4.9% | 1.9% | – | Report on Defibrillator in Spain | |
| $322 Mn | $756 Mn | 8.9% | 1.8% | – | Report on Defibrillator in India | |
| $301 Mn | $616 Mn | 7.4% | 1.7% | – | Report on Defibrillator in Saudi Arabia | |
| $266 Mn | $483 Mn | 6.2% | 1.5% | – | Report on Defibrillator in Mexico | |
| $213 Mn | $434 Mn | 7.4% | 1.2% | – | Report on Defibrillator in Australia | |
| $115 Mn | $230 Mn | 7.1% | 0.6% | – | Report on Defibrillator in South Africa | |
| $89 Mn | $173 Mn | 6.9% | 0.5% | – | Report on Defibrillator in UAE | |
| $50 Mn | $101 Mn | 7.4% | 0.3% | – | Report on Defibrillator in Egypt | |
| $39 Mn | $73 Mn | 6.4% | 0.2% | – | Report on Defibrillator in Philippines | |
| $29 Mn | $52 Mn | 6.1% | 0.2% | – | Report on Defibrillator in Malaysia | |
| $28 Mn | $55 Mn | 6.9% | 0.2% | – | Report on Defibrillator in Hong Kong | |
| $21 Mn | $40 Mn | 6.5% | 0.1% | – | Report on Defibrillator in Singapore | |
| $21 Mn | $39 Mn | 6.2% | 0.1% | – | Report on Defibrillator in Thailand | |
| $12 Mn | $24 Mn | 7% | 0.1% | – | Report on Defibrillator in Kenya | |
| – | – | – | – | – | Report on Defibrillator in New Zealand | |
| – | – | – | – | – | Report on Defibrillator in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Koninklijke Philips N.V.
Nihon Kohden Corporation
Stryker Corporation
Asahi Kasei Corporation
MicroPort Scientific Corporation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Biotronik SE & Co. KG
The world Defibrillator market was worth about $17.7 Bn in 2023 and is projected to reach $31.5 Bn by 2033, growing 5.9% a year (CAGR).
The US is the largest of the 24 countries we cover, at $7.4 Bn in 2023. India grows fastest, at 8.9% a year.
PubMed lists about 9,391 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.